Urgent considerations for the neuro-oncologic treatment of patients with gliomas during the COVID-19 pandemic
Nimish Mohile(University of Rochester Medical Center), Mateo Ziu(Virginia Commonwealth University), Na Tosha Gatson(Geisinger Commonwealth School of Medicine), Martin J. van den Bent(Erasmus MC Cancer Institute), Roy E. Strowd(Wake Forest University), David Schiff(University of Virginia), Andreas F. Hottinger(University of Lausanne), Jaishri O. Blakeley(Johns Hopkins University), Douglas Ney(University of Colorado Denver), Andrew B. Lassman(Columbia University), Helen A. Shih(Massachusetts General Hospital), Adriana Olar(Medical University of South Carolina)
Cited by 79
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k